Piramal Pharma Limited, a active public limited company, was established on 04 March 2020 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24297MH2020PLC338592. Registered under ROC Roc Mumbai. it is listed on BSE: 543635. It has an authorized capital of ₹3,000.00 Cr and a paid-up capital of ₹1,329.25 Cr.
It upholds a compliant status. In 2023, it reported revenue of ₹3,784.29 Cr and a net worth of ₹5,261.79 Cr. Employing 3,851 professional, Its leadership includes Nandini Ajay Piramal (Whole-Time Director), Peter D Deyoung (Whole-Time Director), Nathalie Ann Leitch (Director). Past directors included Nandini Ajay Piramal, Peter D Deyoung, Neeraj Bharadwaj. It holds ₹2,430.00 Cr open charges and ₹1,000.00 Cr settled loans. Its latest AGM occurred on 30 July 2025, with the balance sheet filed on 31 March 2025. It is based at Gr. Flr., Piramal Ananta, Agastya Corp. Park, Kamani Junction, Lbs Marg, Kurla, Mumbai, Maharashtra, 400070.
L24297MH2020PLC338592
338592
04 March 2020
₹3,000.00 Cr
₹1,329.25 Cr
Roc Mumbai
Listed (BSE: 543635)
Active
Explore comprehensive insights into Piramal Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nandini Ajay Piramal | Whole-Time Director | 04 Mar 2020 | Current |
| Peter D Deyoung | Whole-Time Director | 04 Mar 2020 | Current |
| Nathalie Ann Leitch | Director | 28 Jan 2025 | Current |
| Sridhar Gorthi | Director | 30 Mar 2022 | Current |
| Jairaj Manohar Purandare | Director | 09 Feb 2021 | Current |
| Peter Andrew Stevenson | Director | 30 Mar 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Apr 2021 | Past |
| Pramod Abcsdd | Director | 06 Oct 2020 | Past |
| Pramod Abcsdd | Director | 14 May 2025 | Past |
| Pramod Abcsdd | Additional Director | 28 Jul 2022 | Past |
| Pramod Abcsdd | Additional Director | 28 Jul 2022 | Past |
| Pramod Abcsdd | Director | 08 Feb 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Piramal Pharma Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.03% increase. The company also saw a substantial fall in profitability, with a 79.74% decrease in profit. The company's net worth moved up by a moderate rise of 3.84%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Piramal Pharma had a promoter holding of 34.79% and a public holding of 65.22%. The company had 1 Subsidiary and 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹24,300,000,000.00
₹10,000,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 May 2025 | Idbi Trusteeship Services Limited | ₹300.00 Cr | Open |
| 12 Dec 2024 | Idbi Trusteeship Services Limited | ₹100.00 Cr | Open |
| 10 Dec 2024 | Idbi Trusteeship Services Limited | ₹100.00 Cr | Open |
| 10 Dec 2024 | Idbi Trusteeship Services Limited | ₹200.00 Cr | Open |
| 10 Sep 2024 | Idbi Trusteeship Services Limited | ₹150.00 Cr | Open |
Explore comprehensive loan charge details -
Piramal Pharma has a workforce of 3851 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Piramal Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Piramal Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Piramal Pharma Limited last Annual general meeting of members was held on 30 Jul 2025 as per latest MCA records. was completed.
The activity A charge with Idbi Trusteeship Services Limited amounted to Rs. 300.00 Cr with Charge ID 101100712 was registered on 19 May 2025. was completed.
The activity Amit Jain was appointed as a Additional Director was appointed as a Additional Director on 14 May 2025 & has been associated with this company since 6 months 13 days . was completed.
Piramal Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
The activity Nathalie Ann Leitch was appointed as a Director was appointed as a Director on 28 Jan 2025 & has been associated with this company since 9 months 27 days . was completed.
Progress on A charge with Idbi Trusteeship Services Limited amounted to Rs. 100.00 Cr with Charge ID 101026540 was registered on 12 Dec 2024. was documented.
The CIN of Piramal Pharma Limited is L24297MH2020PLC338592.
Piramal Pharma Limited is headquartered at Gr. Flr., Piramal Ananta, Agastya Corp. Park, Kamani Junction, Lbs Marg, Kurla, Mumbai, Maharashtra, 400070.
Piramal Pharma Limited was incorporated on 04 March 2020.
The current directors of Piramal Pharma Limited are
The primary industry of Piramal Pharma Limited is Manufacturing.
Piramal Pharma Limited is listed. It is listed on BSE: 543635.
The authorized capital of Piramal Pharma Limited is ₹3,000.00 Cr, and the paid-up capital is ₹1,329.25 Cr.
The compliance status of Piramal Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX